Rheumatology · Greenville, MS
NPI
1992903355
Since 2007
Specialty
Rheumatology
Code 174400000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
1502 S Colorado St
Greenville, MS, 38703
Phone (662) 332-8848
Groups this clinician bills Medicare through
Medicare paid, 2024
$146K
7,209 services
Medicare patients, 2024
281
Average age 74
Drug cost, 2024
$5.4M
4,730 prescriptions
Company payments, 2025
$1,619
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Shabana C Karim was code J0897 (injection, denosumab, 1 mg), 1,440 times for 16 patients. In total Shabana C Karim billed 7,209 services in 25 codes, and Medicare paid $146K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-02-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 1,440 | 16 | $20.44 | $29K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 1,300 | 17 | $0.10 | $129 |
| 99233 Hospital E&M - Subsequent | Facility | 666 | 100 | $93.80 | $62K |
| 99214 Office E&M - Established | Office | 405 | 180 | $77.71 | $31K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 232 | 129 | $10.48 | $2,432 |
| J1885 Injection, ketorolac tromethamine, per 15 mg | Office | 84 | 15 | $0.54 | $45.68 |
| 96372 Injection Administration | Office | 73 | 45 | $10.55 | $770 |
| G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 55 | 54 | $41.24 | $2,268 |
| 77080 Standard X-ray | Office | 34 | 34 | $9.39 | $319 |
| 20610 Joint Injection | Office | 21 | 18 | $36.95 | $776 |
| 99204 Office E&M - New | Office | 12 | 12 | $131.14 | $1,574 |
By year: 2022 $221K for 7,485 services; 2023 $211K for 10,921 services; 2024 $146K for 7,209 services.
Medicare prescription drug claims, 2024
In 2024, the drug Shabana C Karim prescribed most often to Medicare patients was Methotrexate (Methotrexate Sodium), with 707 prescriptions and refills. In total Shabana C Karim wrote 4,730 Medicare prescriptions that cost $5.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Methotrexate Methotrexate Sodium | 707 | 954 | 134 | $10K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 543 | 545 | 81 | $5,663 |
| Hydroxychloroquine Sulfate Generic | 407 | 548 | 82 | $11K |
| Prednisone Generic | 258 | 268 | 65 | $891 |
| Tramadol Hcl Generic | 246 | 246 | 72 | $886 |
| Leflunomide Generic | 220 | 318 | 56 | $8,064 |
| Gabapentin Generic | 171 | 195 | 31 | $1,325 |
| Xeljanz Xr Tofacitinib Citrate | 151 | 151 | 17 | $908K |
| Rinvoq Upadacitinib | 113 | 113 | 16 | $728K |
| Alendronate Sodium Generic | 113 | 159 | 22 | $353 |
| Benlysta Belimumab | 86 | 86 | Under 11 | $433K |
| Prolia Denosumab | 79 | 467 | 50 | $137K |
| Duloxetine Hcl Generic | 73 | 93 | 13 | $614 |
| Folic Acid Generic | 72 | 92 | 16 | $272 |
| Diclofenac Sodium Generic | 68 | 84 | 25 | $1,771 |
Brand drugs: 964 claims; generic drugs: 3,766 claims; opioid claims: 870.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Shabana C Karim $1,619 ($1,619 in general payments such as food, travel and fees) from 16 companies. The largest payer was Amgen Inc. with $205.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 13 | $205 |
| Abbvie Inc. ABBV | 12 | $190 |
| UCB, Inc. UCB.BR | 9 | $178 |
| ANI Pharmaceuticals, Inc. ANIP | 9 | $163 |
| Mallinckrodt Hospital Products Inc. | 7 | $140 |
| AstraZeneca Pharmaceuticals LP AZN | 7 | $123 |
| Penumbra, Inc. PEN | 1 | $118 |
| Novartis Pharmaceuticals Corporation NVS | 6 | $102 |
| Janssen Biotech, Inc. JNJ | 5 | $97.12 |
| Pfizer Inc. PFE | 5 | $95.72 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.